Search - tctmd.com

Displaying 81 - 100 of 599

Sort: Relevancy | Date

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2016

Shelley Wood

July 01, 2016

News Daily News

New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care

Michael O'Riordan

June 29, 2016

News Features

Clots Found in the Left Atrial Appendage: A Big Deal for TAVR?

Todd Neale

June 27, 2016

News Daily News

Persistent Low-Flow Aortic Stenosis After TAVR Linked With Higher 1-Year Mortality

Michael O'Riordan

June 23, 2016

News Conference News TVT 2016

When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care

Michael O'Riordan

June 20, 2016

News Conference News TVT 2016

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

Michael O'Riordan

June 20, 2016

Presentation TVT 2016

TAVR in Bicuspid Aortic Valve Disease: Anatomic Variations, TAVR Outcomes, and Treatment Guidelines How to Treat and When Not to Treat

Presenter: Mathew Williams

June 17, 2016

Presentation TVT 2016

Combined TAVR and Left Atrial Appendage Closure in AS Patients With Atrial Fibrillation: Case Selection, Procedural Consideration, and Clinical Outcomes

Presenter: Fabian Nietlispach

June 17, 2016

Presentation TVT 2016

Complexities of Managing AS Patients With Atrial Fibrillation After TAVR

Presenter: Samir R. Kapadia

June 17, 2016

Presentation TVT 2016

Is There a Role For MitraClip After TAVR in Patients With Significant Residual MR?

Presenter: Brij Maini

June 17, 2016

Presentation TVT 2016

Management Decisions in the Patient With Severe AS and Mitral Regurgitation

Presenter: Marco Barbanti

June 17, 2016

Presentation TVT 2016

Introducing the UNLOAD TAVR Study: Potential Clinical Benefits of TAVR in Patients With Moderate AS and Reduced-EF Heart Failure

Presenter: Nicolas M. Van Mieghem

June 17, 2016

Presentation TVT 2016

The Case for Accelerating Therapy in Patients With Asymptomatic Severe AS

Presenter: Philippe Généreux

June 17, 2016

Presentation TVT 2016

The AS Patient With Severe Lung Disease: Screening and Management Decisions

Presenter: Brij Maini

June 17, 2016

Presentation TVT 2016

Left Main Coronary Disease and AS: Management Approaches With Case Examples

Presenter: Raj Makkar

June 17, 2016

Presentation TVT 2016

Severe Chronic Kidney Disease and TAVR: Clinical Management Recommendations

Presenter: Ganesh Manoharan

June 17, 2016

Presentation TVT 2016

Replacing the Valve Is Usually Sufficient to Manage Severe AS and Coronary Disease

Presenter: Mark J. Russo

June 17, 2016

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

News Conference News TVT 2016

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Shelley Wood

June 17, 2016

Presentation TVT 2016

State-of-the-Art Approach to TAVR in Bicuspid Aortic Valve Disease: From Patient Screening to Device Selection and Procedural Techniques

Presenter: Horst Sievert

June 16, 2016

Advertisement

TCTMD’s Top 10 Most Popular Stories for June 2016

New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care

Clots Found in the Left Atrial Appendage: A Big Deal for TAVR?

Persistent Low-Flow Aortic Stenosis After TAVR Linked With Higher 1-Year Mortality

When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

TAVR in Bicuspid Aortic Valve Disease: Anatomic Variations, TAVR Outcomes, and Treatment Guidelines How to Treat and When Not to Treat

Combined TAVR and Left Atrial Appendage Closure in AS Patients With Atrial Fibrillation: Case Selection, Procedural Consideration, and Clinical Outcomes

Complexities of Managing AS Patients With Atrial Fibrillation After TAVR

Is There a Role For MitraClip After TAVR in Patients With Significant Residual MR?

Management Decisions in the Patient With Severe AS and Mitral Regurgitation

Introducing the UNLOAD TAVR Study: Potential Clinical Benefits of TAVR in Patients With Moderate AS and Reduced-EF Heart Failure

The Case for Accelerating Therapy in Patients With Asymptomatic Severe AS

The AS Patient With Severe Lung Disease: Screening and Management Decisions

Left Main Coronary Disease and AS: Management Approaches With Case Examples

Severe Chronic Kidney Disease and TAVR: Clinical Management Recommendations

Replacing the Valve Is Usually Sufficient to Manage Severe AS and Coronary Disease

What TAVR Needs Next . . . and What It’s Getting

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

State-of-the-Art Approach to TAVR in Bicuspid Aortic Valve Disease: From Patient Screening to Device Selection and Procedural Techniques

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content